1730 related articles for article (PubMed ID: 10953127)
1. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity.
Alvares RA; Silva JA; Barboza AL; Monteiro RT
Int Braz J Urol; 2010; 36(6):732-7. PubMed ID: 21176280
[TBL] [Abstract][Full Text] [Related]
3. Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.
Chen G; Liao L
Int Urol Nephrol; 2011 Sep; 43(3):655-62. PubMed ID: 21110094
[TBL] [Abstract][Full Text] [Related]
4. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
[TBL] [Abstract][Full Text] [Related]
5. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
Reitz A; Stöhrer M; Kramer G; Del Popolo G; Chartier-Kastler E; Pannek J; Burgdörfer H; Göcking K; Madersbacher H; Schumacher S; Richter R; von Tobel J; Schurch B
Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117
[TBL] [Abstract][Full Text] [Related]
6. Botulinum injection is useless on fibrotic neuropathic bladders.
Tiryaki S; Yagmur I; Parlar Y; Ozel K; Akyildiz C; Avanoglu A; Ulman I
J Pediatr Urol; 2015 Feb; 11(1):27.e1-4. PubMed ID: 25448589
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravesical botulinum neurotoxin-A injection on detrusor hyperreflexia in spinal cord injured patients.
Ge XT; Li YF; Wang Q; Zhao JN
Drug Res (Stuttg); 2015 Jun; 65(6):327-31. PubMed ID: 25350080
[TBL] [Abstract][Full Text] [Related]
8. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.
Popat R; Apostolidis A; Kalsi V; Gonzales G; Fowler CJ; Dasgupta P
J Urol; 2005 Sep; 174(3):984-9. PubMed ID: 16094019
[TBL] [Abstract][Full Text] [Related]
9. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
Kuo HC
Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore.
Tow AM; Toh KL; Chan SP; Consigliere D
Ann Acad Med Singap; 2007 Jan; 36(1):11-7. PubMed ID: 17285181
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
Gamé X; Castel-Lacanal E; Bentaleb Y; Thiry-Escudié I; De Boissezon X; Malavaud B; Marque P; Rischmann P
Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of Botulinum-A toxin injection into bladder to treat neurogenic incontinence in patients with spinal cord injury: comparison of two doses].
Fu G; Wu J; Cong H; Zha L; Li D; Ju Y; Chen G; Xiong Z; Liao L
Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3920-3. PubMed ID: 27122214
[TBL] [Abstract][Full Text] [Related]
14. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence.
Grosse J; Kramer G; Stöhrer M
Eur Urol; 2005 May; 47(5):653-9. PubMed ID: 15826758
[TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury.
Nosseir M; Hinkel A; Pannek J
Neurourol Urodyn; 2007; 26(2):228-33. PubMed ID: 16998859
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.
Klaphajone J; Kitisomprayoonkul W; Sriplakit S
Arch Phys Med Rehabil; 2005 Nov; 86(11):2114-8. PubMed ID: 16271557
[TBL] [Abstract][Full Text] [Related]
17. Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury.
Chen SF; Jiang YH; Jhang JF; Kuo HC
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051012
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients.
Chen YC; Kuo HC
Neurourol Urodyn; 2014 Jan; 33(1):129-34. PubMed ID: 23494629
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions.
Bagi P; Biering-Sørensen F
Scand J Urol Nephrol; 2004; 38(6):495-8. PubMed ID: 15841785
[TBL] [Abstract][Full Text] [Related]
20. Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: a pilot study.
Krhut J; Samal V; Nemec D; Zvara P
Spinal Cord; 2012 Dec; 50(12):904-7. PubMed ID: 22801191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]